A Study of RC48-ADC in Subjects With HER2-Positive Advanced Malignant Solid Tumors
Clinical trial NCT02881138 · COMPLETED
Trial details
- NCT number
- NCT02881138
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2020-04-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.